Amgen
AMGN • NASDAQ
Amgen is a drug manufacturers - general company in the healthcare sector trading on NASDAQ, led by CEO Robert A. Bradway, with a market cap of $191.69B.
Market Cap$191.69B
Employees26.7K
CEORobert A. Bradway
CountryUnited States of America
Healthcare
Drug Manufacturers - General
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Amgen FAQ
Common questions about Amgen
Amgen is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $8.6B.
Amgen has approximately 26,700 employees.